References
1. Holsten T, Bens S, Oyen F, et al. Germline variants in SMARCB1 and
other members of the BAF chromatin-remodeling complex across human
disease entities: a meta-analysis. Eur J Hum Genet.2018;26(8):1083-1093.
2. Capper D, Jones DTW, Sill M, et al. DNA methylation-based
classification of central nervous system tumours. Nature.2018;555(7697):469-474.
3. Kehrer-Sawatzki H, Kordes U, Seiffert S, et al. Co-occurrence of
schwannomatosis and rhabdoid tumor predisposition syndrome 1. Mol
Genet Genomic Med. 2018.
4. Swensen JJ, Keyser J, Coffin CM, Biegel JA, Viskochil DH, Williams
MS. Familial occurrence of schwannomas and malignant rhabdoid tumour
associated with a duplication in SMARCB1. J Med Genet.2009;46(1):68-72.
5. Ibrahim GM, Huang A, Halliday W, et al. Cribriform neuroepithelial
tumour: novel clinicopathological, ultrastructural and cytogenetic
findings. Acta Neuropathol. 2011;122(4):511-514.
6. Maitre E, Bertrand P, Maingonnat C, et al. New generation sequencing
of targeted genes in the classical and the variant form of hairy cell
leukemia highlights mutations in epigenetic regulation genes.Oncotarget. 2018;9(48):28866-28876.
7. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the
World Health Organization classification of lymphoid neoplasms.Blood. 2016;127(20):2375-2390.